We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Pieris Pharmaceuticals Inc | NASDAQ:PIRS | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.16 | -1.42% | 11.08 | 8.01 | 11.42 | 11.20 | 10.60 | 10.98 | 31,507 | 01:00:00 |
|
|
|
|
Nevada
|
|
001-37471
|
|
30-0784346
|
(State or other jurisdiction of
incorporation)
|
|
(Commission
File Number)
|
|
(IRS Employer
Identification No.)
|
255 State Street, 9th Floor
Boston, MA
(Address of principal executive offices)
|
|
|
|
02109
(Zip Code)
|
|
☐
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
☐
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
☐
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
☐
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
|
|
PIERIS PHARMACEUTICALS, INC.
|
|
|
|
Dated: May 14, 2019
|
|
/s/ Allan Reine
|
|
|
Allan Reine
|
|
|
Chief Financial Officer
|
1 Year Pieris Pharmaceuticals Chart |
1 Month Pieris Pharmaceuticals Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions